Valuation: Repligen Corporation

Market Cap 10.95B 9.63B 9.11B 8.26B 15.52B 1,051B 15.61B 109B 42.13B 537B 41.12B 40.23B 1,724B P/E 2026 *
257x
P/E 2027 * 112x
Enterprise Value 10.69B 9.4B 8.89B 8.06B 15.14B 1,026B 15.23B 106B 41.11B 524B 40.13B 39.26B 1,682B EV / Sales 2026 *
12.9x
EV / Sales 2027 * 10.8x
Free-Float
94.31%
Yield 2026 *
-
Yield 2027 * -
1 day-0.78%
1 week+3.31%
Current month+6.60%
1 month+6.60%
3 months+40.82%
6 months+73.04%
Current year+17.74%
1 week 181.71
Extreme 181.71
198.87
1 month 161.14
Extreme 161.1416
198.87
Current year 100.99
Extreme 100.99
198.87
1 year 100.99
Extreme 100.99
198.87
3 years 100.99
Extreme 100.99
211.13
5 years 100.99
Extreme 100.99
306.98
10 years 26.16
Extreme 26.16
327.32
Manager TitleAgeSince
Chief Executive Officer 56 2024-08-31
Director of Finance/CFO 52 2023-09-24
Chief Tech/Sci/R&D Officer - 2025-07-31
Director TitleAgeSince
Chairman 74 2011-12-13
Director/Board Member 60 2014-06-11
Director/Board Member 67 2015-09-30
Date Insider Type Main position Quantity % Market Cap. Importance
9/25/26 Tax

Chief Financial Officer

-421 0.0007%
9/24/26 Exercice

Chief Executive Officer

38,838 0.0688%
9/21/26 Exercice

Chief Executive Officer

16,278 0.0288%
Change 5-day change 1-year change 3-year change Capi.($)
-0.78%+3.31%+55.47%+21.33% 10.95B
-1.13%-3.80%-25.06%+2.99% 175B
-1.89%-3.22%-6.52%+12.10% 114B
-0.57%-4.18%-2.20%+67.41% 57.98B
-1.69%-1.13%-1.66%-30.01% 50.07B
-1.00%+0.37%+14.24%+51.55% 50.13B
-1.32%-4.11%+29.18%-7.98% 32.71B
-0.37%+1.38% - - 30.77B
-0.81%+0.13%+42.73%-0.97% 26.44B
+0.28%+5.23%+26.98%-3.89% 23.96B
Average -0.93%+2.15%+14.79%+12.50% 57.22B
Weighted average by Cap. -1.16%-0.04%-2.37%+12.47%

Financials

2026 *2027 *
Net sales 827M 727M 688M 624M 1.17B 79.4B 1.18B 8.24B 3.18B 40.52B 3.11B 3.04B 130B 974M 857M 810M 735M 1.38B 93.54B 1.39B 9.7B 3.75B 47.73B 3.66B 3.58B 153B
Net income 41.92M 36.87M 34.87M 31.62M 59.39M 4.02B 59.73M 417M 161M 2.05B 157M 154M 6.6B 98.84M 86.93M 82.2M 74.56M 140M 9.49B 141M 984M 380M 4.84B 371M 363M 15.56B
Net Debt -265M -233M -220M -200M -375M -25.43B -377M -2.64B -1.02B -12.97B -994M -973M -41.69B -438M -385M -364M -330M -621M -42.05B -624M -4.36B -1.68B -21.46B -1.64B -1.61B -68.95B
Logo Repligen Corporation
Repligen Corporation is a global life sciences company that develops and commercializes bioprocessing technologies and systems. Its franchises include filtration, chromatography, process analytics and proteins. Its filtration franchise includes product offering covering upstream and downstream technologies. Its filtration products include XCell Alternating Tangential Flow (ATF) Cell Retention Systems, Flat Sheet Cassettes, Hollow Fiber Consumables, Tangential Flow Filtration Systems and Fluid Management. Its chromatography franchise includes products used in downstream purification, development, manufacturing and quality control of biological drugs. Its chromatography franchise includes OPUS Pre-Packed Columns, KRM Chromatography Systems and other additional chromatography products. Its process analytics include Downstream process analytical technology (PAT) and Upstream PAT. Its Proteins include Protein A Affinity Ligands, AVIPure Resins for New Modalities and Growth Factors.
Employees
2,000
Date Price Change Volume
26-09-29 $192.28 -0.93% 309,539
26-09-28 $194.09 +2.32% 1,567,198
26-09-25 $189.68 -0.51% 1,502,366
26-09-24 $190.65 +3.32% 1,602,615
26-09-23 $184.53 -1.19% 934,768
Trader
Investor
Global
Quality
ESG MSCI
AA
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
23
Last Close Price
194.09USD
Average target price
189.48USD
Spread / Average Target
-2.38%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. RGEN Stock